Limited Use Note(s) |
|
ANAGRELIDE HCL0.5mg Cap
| Reason For Use Code | Clinical Criteria |
|---|---|
| 400 | For the treatment of essential thrombocytosis in patients who are intolerant of or who have failed hydroxyurea therapy. |
| LU Authorization Period: 5 years. |